GILD - big money call buying

Whilst the main market continued to battle upward, there was powerful strength within Gilead Sciences (GILD) which settled +5.0% at $78.10. There is a clear bullish breakout, and the door is open to first big target of $90. With an FPE in the 10s, yours truly is m/t bullish to $100/10 before year end.


GILD daily

GILD monthly

Summary

Gilead Sciences saw a decisive bullish breakout, pushing straight through resistance in the $76s. Seen on the bigger monthly chart, the January candle is giving major support to the notion of the key higher low of $69.57 seen last November. Soft target has to be around $90.

Interestingly today, there was notable call buying in the May $90 calls...

Pete Najarian of investitute.com highlighting unusual activity

Today's 'big money' call buying is a good sign, and gives extra confidence that my original outlook is soundly based.
--


This afternoon, Gilead caught further mainstream attention, via the JPM health conference...

--
With an FPE in the 10s, the stock is unquestionably superb value, and could easily see $90 by late Feb/March.

yours... no fan of health/bio stocks, but GILD is 'fine'.